+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Hematology Analyzers Market Outlook 2026-2036

  • PDF Icon

    Report

  • 218 Pages
  • November 2025
  • Region: Global
  • Research Nester Pvt. Ltd
  • ID: 6216418
The global hematology analyzers market was valued at USD 8.00 billion in 2025 and is projected to reach USD 16.10 billion by 2036, rising at a CAGR of 7.2% (2026-2036). In 2026, the market size is expected to be USD 8.60 billion.

Report Scope

  • Overview of the market, value chain, and ecosystem
  • Research methodology, analytical approach, and data validation process
  • Executive summary highlighting key findings, market dynamics, and insights
  • Analysis of growth drivers, constraints, opportunities, trends, and regulatory impact
  • Market outlook with forward-looking projections and scenario-based forecasting
  • Competitive white space and untapped opportunity identification
  • Assessment of risks, challenges, and uncertainties
  • SWOT, PESTLE, Porter’s Five Forces, and Root Cause Analysis frameworks
  • Technological advancements and technology maturity mapping
  • Tracking of recent developments, product launches, and strategic initiatives
  • Regional demand analysis and comparative geographic positioning
  • Strategic segment analysis and demand trends
  • Competitive landscape, market share distribution, and investor-focused benchmarking
  • Impact of global economic conditions on market performance

Table of Contents

1. An Outline of the Global Hematology Analyzers Market
1.1. Market Definition and Segmentation
1.2. Study Assumptions and Abbreviations
2. Research Methodology & Approach
2.1. Primary Research
2.2. Secondary Research
2.3. Data Triangulation
2.4. SPSS Methodology
3. Executive Summary4. Growth Drivers5. Major Roadblocks6. Opportunities7. Prevalent Trends8. Government Regulation9. Growth Outlook10. Competitive White Space Analysis - Identifying Untapped Market Gaps11. Risk Overview12. SWOT13. Technological Advancement14. Technology Maturity Matrix for Hematology Analyzers15. Recent News16. Regional Demand17. Hematology Analyzers Market by Geography - Strategic Comparative Analysis18. Strategic Segment Analysis: Hematology Analyzers Demand Landscape19. Hematology Analyzers Demand Trends Driven by Electrification, Downsizing, and Lightweighting (2026-2036)20. Root Cause Analysis (RCA) for discovering problems of the Hematology Analyzers Market21. Porter Five Forces22. PESTLE23. Comparative Positioning24. Global Hematology Analyzers Market - Key Player Analysis (2024)25. Competitive Landscape: Key Suppliers/Players26. Competitive Model: A Detailed Inside View for Investors
27. Company Market Share, 2025 (%)
27.1. Business Profile of Key Enterprise
27.1.1. Abbott Laboratories
27.1.2. Sysmex Corporation
27.1.3. Beckman Coulter
27.1.4. Siemens Healthineers
27.1.5. Danaher Corporation
27.1.6. F. Hoffmann-La Roche Ltd.
27.1.7. Bio-Rad Laboratories
27.1.8. HORIBA Ltd.
27.1.9. Mindray Medical International Limited
27.1.10. Nihon Kohden Corporation
27.1.11. Boule Diagnostics AB
27.1.12. Ortho Clinical Diagnostics
27.1.13. Diatron MI PLC
27.1.14. Thermo Fisher Scientific Inc.
27.1.15. Agilent Technologies Inc.
28. Global Hematology Analyzers Market Outlook
28.1. Market Overview
28.1.1. Market Revenue by Value (USD Million), Volume (Thousand Tons), and Compound Annual Growth Rate (CAGR)
28.2. Hematology Analyzers Market Segmentation Analysis (2026-2036), By
28.2.1. Product Type
28.2.1.1. 3-Part Differential Hematology Analyzers, Market Value (USD Million), and CAGR, 2026-2036F
28.2.1.2. 5-Part Differential Hematology Analyzers, Market Value (USD Million), and CAGR, 2026-2036F
28.2.1.3. 6-Part and Above/High-End Analyzers, Market Value (USD Million), and CAGR, 2026-2036F
28.2.1.4. Point-of-Care Hematology Analyzers, Market Value (USD Million), and CAGR, 2026-2036F
28.2.1.5. Hematology Reagents & Consumables, Market Value (USD Million), and CAGR, 2026-2036F
28.2.2. Modality
28.2.2.1. Benchtop, Market Value (USD Million), and CAGR, 2026-2036F
28.2.2.2. Floor-Standing, Market Value (USD Million), and CAGR, 2026-2036F
28.2.3. Application
28.2.3.1. Complete Blood Count (CBC), Market Value (USD Million), and CAGR, 2026-2036F
28.2.3.2. Reticulocyte Testing, Market Value (USD Million), and CAGR, 2026-2036F
28.2.3.3. Others, Market Value (USD Million), and CAGR, 2026-2036F
28.2.4. Automation Level
28.2.4.1. Fully Automated Hematology Analyzers, Market Value (USD Million), and CAGR, 2026-2036F
28.2.4.2. Semi-Automated Hematology Analyzers, Market Value (USD Million), and CAGR, 2026-2036F
28.2.5. End use
28.2.5.1. Hospitals, Market Value (USD Million), and CAGR, 2026-2036F
28.2.5.2. Diagnostic Laboratories, Market Value (USD Million), and CAGR, 2026-2036F
28.2.5.3. Clinics/Outpatient Centers, Market Value (USD Million), and CAGR, 2026-2036F
28.2.5.4. Others, Market Value (USD Million), and CAGR, 2026-2036F
28.2.6. Regional Synopsis, Value (USD Million), 2026-2036
28.2.6.1. North America Market Value (USD Million) and CAGR & Y-o-Y Growth Trend, 2026-2036F
28.2.6.2. Europe Market Value (USD Million) and CAGR & Y-o-Y Growth Trend, 2026-2036F
28.2.6.3. Asia Pacific Market Value (USD Million) and CAGR & Y-o-Y Growth Trend, 2026-2036F
28.2.6.4. Latin America Market Value (USD Million) and CAGR & Y-o-Y Growth Trend, 2026-2036F
28.2.6.5. Middle East and Africa Market Value (USD Million) and CAGR & Y-o-Y Growth Trend, 2026-2036F
29. North America Market
29.1. Overview
29.1.1. Market Value (USD Million), Current and Future Projections, 2026-2036
29.1.2. Increment $ Opportunity Assessment, 2026-2036
29.2. Segmentation (USD million), 2026-2036, By
29.2.1. Product Type
29.2.1.1. 3-Part Differential Hematology Analyzers, Market Value (USD Million), and CAGR, 2026-2036F
29.2.1.2. 5-Part Differential Hematology Analyzers, Market Value (USD Million), and CAGR, 2026-2036F
29.2.1.3. 6-Part and Above/High-End Analyzers, Market Value (USD Million), and CAGR, 2026-2036F
29.2.1.4. Point-of-Care Hematology Analyzers, Market Value (USD Million), and CAGR, 2026-2036F
29.2.1.5. Hematology Reagents & Consumables, Market Value (USD Million), and CAGR, 2026-2036F
29.2.2. Modality
29.2.2.1. Benchtop, Market Value (USD Million), and CAGR, 2026-2036F
29.2.2.2. Floor-Standing, Market Value (USD Million), and CAGR, 2026-2036F
29.2.3. Application
29.2.3.1. Complete Blood Count (CBC), Market Value (USD Million), and CAGR, 2026-2036F
29.2.3.2. Reticulocyte Testing, Market Value (USD Million), and CAGR, 2026-2036F
29.2.3.3. Others, Market Value (USD Million), and CAGR, 2026-2036F
29.2.4. Automation Level
29.2.4.1. Fully Automated Hematology Analyzers, Market Value (USD Million), and CAGR, 2026-2036F
29.2.4.2. Semi-Automated Hematology Analyzers, Market Value (USD Million), and CAGR, 2026-2036F
29.2.5. End use
29.2.5.1. Hospitals, Market Value (USD Million), and CAGR, 2026-2036F
29.2.5.2. Diagnostic Laboratories, Market Value (USD Million), and CAGR, 2026-2036F
29.2.5.3. Clinics/Outpatient Centers, Market Value (USD Million), and CAGR, 2026-2036F
29.2.5.4. Others, Market Value (USD Million), and CAGR, 2026-2036F
29.2.6. Country Level Analysis, Value (USD Million)
29.2.6.1. U.S. Market Value (USD Million) and CAGR & Y-o-Y Growth Trend, 2026-2036F
29.2.6.2. Canada Market Value (USD Million) and CAGR & Y-o-Y Growth Trend, 2026-2036F
30. Europe Market
30.1. Overview
30.1.1. Market Value (USD Million), Current and Future Projections, 2026-2036
30.1.2. Increment $ Opportunity Assessment, 2026-2036
30.2. Segmentation (USD million), 2026-2036, By
30.2.1. Product Type
30.2.1.1. 3-Part Differential Hematology Analyzers, Market Value (USD Million), and CAGR, 2026-2036F
30.2.1.2. 5-Part Differential Hematology Analyzers, Market Value (USD Million), and CAGR, 2026-2036F
30.2.1.3. 6-Part and Above/High-End Analyzers, Market Value (USD Million), and CAGR, 2026-2036F
30.2.1.4. Point-of-Care Hematology Analyzers, Market Value (USD Million), and CAGR, 2026-2036F
30.2.1.5. Hematology Reagents & Consumables, Market Value (USD Million), and CAGR, 2026-2036F
30.2.2. Modality
30.2.2.1. Benchtop, Market Value (USD Million), and CAGR, 2026-2036F
30.2.2.2. Floor-Standing, Market Value (USD Million), and CAGR, 2026-2036F
30.2.3. Application
30.2.3.1. Complete Blood Count (CBC), Market Value (USD Million), and CAGR, 2026-2036F
30.2.3.2. Reticulocyte Testing, Market Value (USD Million), and CAGR, 2026-2036F
30.2.3.3. Others, Market Value (USD Million), and CAGR, 2026-2036F
30.2.4. Automation Level
30.2.4.1. Fully Automated Hematology Analyzers, Market Value (USD Million), and CAGR, 2026-2036F
30.2.4.2. Semi-Automated Hematology Analyzers, Market Value (USD Million), and CAGR, 2026-2036F
30.2.5. End use
30.2.5.1. Hospitals, Market Value (USD Million), and CAGR, 2026-2036F
30.2.5.2. Diagnostic Laboratories, Market Value (USD Million), and CAGR, 2026-2036F
30.2.5.3. Clinics/Outpatient Centers, Market Value (USD Million), and CAGR, 2026-2036F
30.2.5.4. Others, Market Value (USD Million), and CAGR, 2026-2036F
30.2.6. Country Level Analysis, Value (USD Million)
30.2.6.1. UK Market Value (USD Million) and CAGR & Y-o-Y Growth Trend, 2026-2036F
30.2.6.2. Germany Market Value (USD Million) and CAGR & Y-o-Y Growth Trend, 2026-2036F
30.2.6.3. France Market Value (USD Million) and CAGR & Y-o-Y Growth Trend, 2026-2036F
30.2.6.4. Italy Market Value (USD Million) and CAGR & Y-o-Y Growth Trend, 2026-2036F
30.2.6.5. Spain Market Value (USD Million) and CAGR & Y-o-Y Growth Trend, 2026-2036F
30.2.6.6. Netherlands Market Value (USD Million) and CAGR & Y-o-Y Growth Trend, 2026-2036F
30.2.6.7. Russia Market Value (USD Million) and CAGR & Y-o-Y Growth Trend, 2026-2036F
30.2.6.8. Switzerland Market Value (USD Million) and CAGR & Y-o-Y Growth Trend, 2026-2036F
30.2.6.9. Poland Market Value (USD Million) and CAGR & Y-o-Y Growth Trend, 2026-2036F
30.2.6.10. Belgium Market Value (USD Million) and CAGR & Y-o-Y Growth Trend, 2026-2036F
30.2.6.11. Rest of Europe Market Value (USD Million) and CAGR & Y-o-Y Growth Trend, 2026-2036F
31. Asia Pacific Market
31.1. Overview
31.1.1. Market Value (USD Million), Current and Future Projections, 2026-2036
31.1.2. Increment $ Opportunity Assessment, 2026-2036
31.2. Segmentation (USD million), 2026-2036, By
31.2.1. Product Type
31.2.1.1. 3-Part Differential Hematology Analyzers, Market Value (USD Million), and CAGR, 2026-2036F
31.2.1.2. 5-Part Differential Hematology Analyzers, Market Value (USD Million), and CAGR, 2026-2036F
31.2.1.3. 6-Part and Above/High-End Analyzers, Market Value (USD Million), and CAGR, 2026-2036F
31.2.1.4. Point-of-Care Hematology Analyzers, Market Value (USD Million), and CAGR, 2026-2036F
31.2.1.5. Hematology Reagents & Consumables, Market Value (USD Million), and CAGR, 2026-2036F
31.2.2. Modality
31.2.2.1. Benchtop, Market Value (USD Million), and CAGR, 2026-2036F
31.2.2.2. Floor-Standing, Market Value (USD Million), and CAGR, 2026-2036F
31.2.3. Application
31.2.3.1. Complete Blood Count (CBC), Market Value (USD Million), and CAGR, 2026-2036F
31.2.3.2. Reticulocyte Testing, Market Value (USD Million), and CAGR, 2026-2036F
31.2.3.3. Others, Market Value (USD Million), and CAGR, 2026-2036F
31.2.4. Automation Level
31.2.4.1. Fully Automated Hematology Analyzers, Market Value (USD Million), and CAGR, 2026-2036F
31.2.4.2. Semi-Automated Hematology Analyzers, Market Value (USD Million), and CAGR, 2026-2036F
31.2.5. End use
31.2.5.1. Hospitals, Market Value (USD Million), and CAGR, 2026-2036F
31.2.5.2. Diagnostic Laboratories, Market Value (USD Million), and CAGR, 2026-2036F
31.2.5.3. Clinics/Outpatient Centers, Market Value (USD Million), and CAGR, 2026-2036F
31.2.5.4. Others, Market Value (USD Million), and CAGR, 2026-2036F
31.2.6. Country Level Analysis, Value (USD Million)
31.2.6.1. China Market Value (USD Million) and CAGR & Y-o-Y Growth Trend, 2026-2036F
31.2.6.2. India Market Value (USD Million) and CAGR & Y-o-Y Growth Trend, 2026-2036F
31.2.6.3. South Korea Market Value (USD Million) and CAGR & Y-o-Y Growth Trend, 2026-2036F
31.2.6.4. Australia Market Value (USD Million) and CAGR & Y-o-Y Growth Trend, 2026-2036F
31.2.6.5. Indonesia Market Value (USD Million) and CAGR & Y-o-Y Growth Trend, 2026-2036F
31.2.6.6. Malaysia Market Value (USD Million) and CAGR & Y-o-Y Growth Trend, 2026-2036F
31.2.6.7. Vietnam Market Value (USD Million) and CAGR & Y-o-Y Growth Trend, 2026-2036F
31.2.6.8. Thailand Market Value (USD Million) and CAGR & Y-o-Y Growth Trend, 2026-2036F
31.2.6.9. Singapore Market Value (USD Million) and CAGR & Y-o-Y Growth Trend, 2026-2036F
31.2.6.10. New Zeeland Market Value (USD Million) and CAGR & Y-o-Y Growth Trend, 2026-2036F
31.2.6.11. Rest of Asia Pacific Excluding Japan Market Value (USD Million) and CAGR & Y-o-Y Growth Trend, 2026-2036F
32. Latin America Market
32.1. Overview
32.1.1. Market Value (USD Million), Current and Future Projections, 2026-2036
32.1.2. Increment $ Opportunity Assessment, 2026-2036
32.1.3. Year-on-Year Growth Forecast (%)
32.2. Segmentation (USD million), 2026-2036, By
32.2.1. Product Type
32.2.1.1. 3-Part Differential Hematology Analyzers, Market Value (USD Million), and CAGR, 2026-2036F
32.2.1.2. 5-Part Differential Hematology Analyzers, Market Value (USD Million), and CAGR, 2026-2036F
32.2.1.3. 6-Part and Above/High-End Analyzers, Market Value (USD Million), and CAGR, 2026-2036F
32.2.1.4. Point-of-Care Hematology Analyzers, Market Value (USD Million), and CAGR, 2026-2036F
32.2.1.5. Hematology Reagents & Consumables, Market Value (USD Million), and CAGR, 2026-2036F
32.2.2. Modality
32.2.2.1. Benchtop, Market Value (USD Million), and CAGR, 2026-2036F
32.2.2.2. Floor-Standing, Market Value (USD Million), and CAGR, 2026-2036F
32.2.3. Application
32.2.3.1. Complete Blood Count (CBC), Market Value (USD Million), and CAGR, 2026-2036F
32.2.3.2. Reticulocyte Testing, Market Value (USD Million), and CAGR, 2026-2036F
32.2.3.3. Others, Market Value (USD Million), and CAGR, 2026-2036F
32.2.4. Automation Level
32.2.4.1. Fully Automated Hematology Analyzers, Market Value (USD Million), and CAGR, 2026-2036F
32.2.4.2. Semi-Automated Hematology Analyzers, Market Value (USD Million), and CAGR, 2026-2036F
32.2.5. End use
32.2.5.1. Hospitals, Market Value (USD Million), and CAGR, 2026-2036F
32.2.5.2. Diagnostic Laboratories, Market Value (USD Million), and CAGR, 2026-2036F
32.2.5.3. Clinics/Outpatient Centers, Market Value (USD Million), and CAGR, 2026-2036F
32.2.5.4. Others, Market Value (USD Million), and CAGR, 2026-2036F
32.2.6. Country Level Analysis, Value (USD Million)
32.2.6.1. Brazil Market Value (USD Million) and CAGR & Y-o-Y Growth Trend, 2026-2036F
32.2.6.2. Argentina Market Value (USD Million) and CAGR & Y-o-Y Growth Trend, 2026-2036F
32.2.6.3. Mexico Market Value (USD Million) and CAGR & Y-o-Y Growth Trend, 2026-2036F
32.2.6.4. Rest of Latin America Market Value (USD Million) and CAGR & Y-o-Y Growth Trend, 2026-2036F
33. Middle East & Africa Market
33.1. Overview
33.1.1. Market Value (USD Million), Current and Future Projections, 2026-2036
33.1.2. Increment $ Opportunity Assessment, 2026-2036
33.1.3. Year-on-Year Growth Forecast (%)
33.2. Segmentation (USD million), 2026-2036, By
33.2.1. Product Type
33.2.1.1. 3-Part Differential Hematology Analyzers, Market Value (USD Million), and CAGR, 2026-2036F
33.2.1.2. 5-Part Differential Hematology Analyzers, Market Value (USD Million), and CAGR, 2026-2036F
33.2.1.3. 6-Part and Above/High-End Analyzers, Market Value (USD Million), and CAGR, 2026-2036F
33.2.1.4. Point-of-Care Hematology Analyzers, Market Value (USD Million), and CAGR, 2026-2036F
33.2.1.5. Hematology Reagents & Consumables, Market Value (USD Million), and CAGR, 2026-2036F
33.2.2. Modality
33.2.2.1. Benchtop, Market Value (USD Million), and CAGR, 2026-2036F
33.2.2.2. Floor-Standing, Market Value (USD Million), and CAGR, 2026-2036F
33.2.3. Application
33.2.3.1. Complete Blood Count (CBC), Market Value (USD Million), and CAGR, 2026-2036F
33.2.3.2. Reticulocyte Testing, Market Value (USD Million), and CAGR, 2026-2036F
33.2.3.3. Others, Market Value (USD Million), and CAGR, 2026-2036F
33.2.4. Automation Level
33.2.4.1. Fully Automated Hematology Analyzers, Market Value (USD Million), and CAGR, 2026-2036F
33.2.4.2. Semi-Automated Hematology Analyzers, Market Value (USD Million), and CAGR, 2026-2036F
33.2.5. End use
33.2.5.1. Hospitals, Market Value (USD Million), and CAGR, 2026-2036F
33.2.5.2. Diagnostic Laboratories, Market Value (USD Million), and CAGR, 2026-2036F
33.2.5.3. Clinics/Outpatient Centers, Market Value (USD Million), and CAGR, 2026-2036F
33.2.5.4. Others, Market Value (USD Million), and CAGR, 2026-2036F
33.2.6. Country Level Analysis, Value (USD Million)
33.2.6.1. Saudi Arabia Market Value (USD Million) and CAGR & Y-o-Y Growth Trend, 2026-2036F
33.2.6.2. UAE Market Value (USD Million) and CAGR & Y-o-Y Growth Trend, 2026-2036F
33.2.6.3. Israel Market Value (USD Million) and CAGR & Y-o-Y Growth Trend, 2026-2036F
33.2.6.4. Qatar Market Value (USD Million) and CAGR & Y-o-Y Growth Trend, 2026-2036F
33.2.6.5. Kuwait Market Value (USD Million) and CAGR & Y-o-Y Growth Trend, 2026-2036F
33.2.6.6. Oman Market Value (USD Million) and CAGR & Y-o-Y Growth Trend, 2026-2036F
33.2.6.7. South Africa Market Value (USD Million) and CAGR & Y-o-Y Growth Trend, 2026-2036F
33.2.6.8. Rest of Middle East & Africa Market Value (USD Million) and CAGR & Y-o-Y Growth Trend, 2026-2036F
34. Global Economic Scenario
34.1. World Economic Outlook
35. About the Analyst
35.1. Global Clientele
35.2. Clients Served Across World

Companies Mentioned

  • Abbott Laboratories
  • Sysmex Corporation
  • Beckman Coulter
  • Siemens Healthineers
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • Bio-Rad Laboratories
  • HORIBA Ltd.
  • Mindray Medical International Limited
  • Nihon Kohden Corporation
  • Boule Diagnostics AB
  • Ortho Clinical Diagnostics
  • Diatron MI PLC
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies Inc.